Cardiovascular Pathology
Volume 20, Issue 3 , Pages 146-155 , May 2011

Phenotypic modulation and turnover of bone marrow-derived cells after myocardial infarction in rats

  • Daisuke Sato

      Affiliations

    • Second Department of Internal Medicine, Kansai Medical University, Moriguchi City, Japan
    • ,
  • Hajime Otani

      Affiliations

    • Second Department of Internal Medicine, Kansai Medical University, Moriguchi City, Japan
    • Corresponding Author InformationCorresponding author. The Second Department of Internal Medicine, Kansai Medical University, Moriguchi City, Japan. Tel.: +81 6 6992 1001; fax: +81 6 6994 7022.
    • ,
  • Chiharu Enoki

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Kansai Medical University, Moriguchi City, Japan
    • ,
  • Masanori Fujita

      Affiliations

    • Second Department of Internal Medicine, Kansai Medical University, Moriguchi City, Japan
    • ,
  • Naoki Minato

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Kansai Medical University, Moriguchi City, Japan
    • ,
  • Toshiji Iwasaka

      Affiliations

    • Second Department of Internal Medicine, Kansai Medical University, Moriguchi City, Japan

Received 7 December 2009 ,Revised 25 March 2010 ,Accepted 12 April 2010.

References 

  1. Leone AM, Rutella S, Bonanno G, Contemi AM, de Ritis DG, Giannico MB, et al. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol. 2006;111:202–208
  2. Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol. 2005;39:363–376
  3. Wojakowski W, Tendera M. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol. 2005;43:229–232
  4. Odorfer KI, Walter I, Kleiter M, Sandgren EP, Erben RG. Role of endogenous bone marrow cells in long-term repair mechanisms after myocardial infarction. J Cell Mol Med. 2008;12:2867–2874
  5. Kushida T, Inaba M, Hisha H, Ichioka N, Esumi T, Ogawa R, et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood. 2001;97:3292–3299
  6. Esumi T, Inaba M, Ichioka N, Kushida T, Iida H, Ikehara S. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation. 2003;76:1543–1548
  7. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31–47
  8. Lu L, Zhang JQ, Ramires FJ, Sun Y. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun. 2004;320:907–913
  9. Schachinger V, Aicher A, Dobert N, Rover R, Diener J, Fichtlscherer S, et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation. 2008;118:1425–1432
  10. Enoki C, Otani H, Sato D, Okada T, Hattori R, Imamura H. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction. Int J Cardiol. 2010;138:9–18
  11. Metharom P, Doyle B, Caplice NM. Clinical trials in stem cell therapy: pitfalls and lessons for the future. Nat Clin Pract Cardiovasc Med. 2007;4(Suppl 1):S96–S99
  12. Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg. 2007;6:593–597
  13. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664–668
  14. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10:494–501
  15. Tatsumi K, Otani H, Sato D, Enoki C, Iwasaka T, Imamura H, et al. Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J. 2008;72:1351–1358
  16. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004;104:3581–3587
  17. Pearson JD. Endothelial progenitor cells — hype or hope?. J Thromb Haemost. 2009;7:255–262
  18. Mollmann H, Nef HM, Kostin S, von Kalle C, Pilz I, Weber M, et al. Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res. 2006;71:661–671
  19. van Amerongen MJ, Bou-Gharios G, Popa E, van Ark J, Petersen AH, van Dam GM, et al. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol. 2008;214:377–386
  20. Yano T, Miura T, Ikeda Y, Matsuda E, Saito K, Miki T, et al. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc Pathol. 2005;14:241–246
  21. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009;114:723–732
  22. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989–997

 There is no conflict of interest to disclose.

 This study was supported in part by Research Grant 18791004 from the Ministry of Education, Science, and Culture of Japan.

PII: S1054-8807(10)00048-7

doi: 10.1016/j.carpath.2010.04.001

Cardiovascular Pathology
Volume 20, Issue 3 , Pages 146-155 , May 2011

Article Tools

* Image Usage & Resolution